Navigation Links
caprotec bioanalytics GmbH Appoints Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer
Date:10/4/2010

Karlheinz Schmelig, Partner with Creathor Ventures and Ute Mercker, Fond Manager at Beteiligungsgesellschaft mbH of the Investitionsbank Berlin.

Before joining caprotec, Prof. Metternich was Vice President and Basic Research Site Head at Merck & Co in West Point, PA. Prior to that, he was Executive Vice President and Member of the Executive Committee at Schering AG in Berlin, and, before that, was Global Senior Chemistry Expert at Novartis in Basel.  He earned his doctorate degree in organic chemistry from the University at Marburg, Germany, was a postdoctoral fellow at Harvard University with Professor David A. Evans and spent a Sabbatical at the University of California, Berkeley with Professor Paul A. Bartlett. He is on the editorial board of several leading scientific journals and a member of several Scientific Advisory Boards of academic, private and non-profit research organizations. He is the author of many peer-reviewed scientific publications.

About caprotec bioanalytics GmbH

caprotec bioanalytics is headquartered in Berlin, Germany with a US subsidiary in Burlington, MA. The company focuses on the commercialization of its proprietary Capture Compound Mass Spectrometry™ (CCMS) technology. The core of the CCMS technology consists of small, tri-functional molecules called Capture Compounds (CCs). They enable a targeted isolation of proteins directly from complex biological samples. After isolation the captured proteins are identified and characterized by mass spectrometry. Providing a state-of-the-art platform for the isolation and analysis of proteins from complex mixtures, the CCMS technology has enormous potential in proteomics, drug development and the development of biomarkers. The technology is protected by a broad patent portfolio. The company is supported by an international scientific advisory board including one Nobel Laureate.

www.caprotec.com


'/>"/>
SOURCE caprotec bioanalytics GmbH
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors
2. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
3. EUCODIS Bioscience Appoints Two Industry Executives to Realigned Advisory Board
4. ONCOTHYREON APPOINTS JULIE M. EASTLAND AS CHIEF FINANCIAL OFFICER
5. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
6. Verenium Appoints Kevin Bracken Vice President of Manufacturing
7. Kendle Appoints Jeffrey M. Zucker to Lead Global Patient Recruitment Efforts
8. TASC, Inc. Appoints Rashid Chotani to Lead Chemical-Biological Defense Programs
9. Tengion Appoints A. Brian Davis Chief Financial Officer
10. CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
11. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... Culture Market 2014-2018" report to their offering.  ... culture is the in vitro growth of plant or ... studies, and biopharmaceutical production. Cell culture is a crucial ... instruments and cell culture consumables are necessary for the ...
(Date:7/24/2014)... Three companies from the angelMD network ... C Competition. Out of 700 competition entrants, Chiron Health, ... semi-final round. In this round twenty teams are invited ... with mentoring from thought-leaders and medical entrepreneurs from all ... angelMD commitment to the Livestrong vision around the Big ...
(Date:7/24/2014)... Canada (PRWEB) July 24, 2014 The ... Optimizing Dose Escalation in First in Human Studies” will ... make better go/no-go decisions. , With increasing R&D costs ... pharmaceutical companies need to maximize the knowledge collected in ... decisions and improve success in late stage development. , ...
Breaking Biology Technology:Nano-sized chip 'sniffs out' explosives far better than trained dogs 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... experience in multi-GPU high-performance computing systems designed ... scientists, engineers and researchers with a GPU-based ... (PSC), which will be shown at the ... Conference, the top international conference for high ...
... the First Time , ... San Diego, CA (PRWEB) ... a regenerative medicine company developing solutions based on the products of ... of Regenerative Medicine conference, taking place November 17-18, 2008 in London. ...
... Henderson LLP, one of Canada,s Largest Law firms, has implemented a ... The firm has leveraged FileTrail Web Services to integrate physical records ... the Firm,s 2,000 employees. , ... San Jose, CA ...
Cached Biology Technology:BOXX Personal Supercomputer for Research Scientists Featured at SC08 2Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine 2Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine 3Gowlings Adopts RFID and Unifies Practice Management 2Gowlings Adopts RFID and Unifies Practice Management 3Gowlings Adopts RFID and Unifies Practice Management 4
(Date:7/27/2014)... like bacteria and fungi can evade treatment by acquiring ... drugs. These permanent mutations were once thought to be ... a new study has shown that microorganisms can use ... epimutations -- to gain the benefits of drug resistance ... discovered in a fungus called Mucor circinelloides, it is ...
(Date:7/27/2014)... Using data from over 18,000 patients, scientists have ... involved in Parkinson,s disease, including six that had ... Nature Genetics , was partially funded by ... by scientists working in NIH laboratories. , "Unraveling ... understanding the multiple mechanisms involved in this complex ...
(Date:7/25/2014)... and some of the smoke from those fires is drifting ... the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua satellite ... over the Great Lakes region of the United States. ... 23, 2014 (first image feature highlighted below) clearly shows the ... In the image, it is over Manitoba and parts ...
Breaking Biology News(10 mins):Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3NIH scientists find 6 new genetic risk factors for Parkinson's 2
... University Bloomington scientists will use knowledge about methane production ... in on evidence for similar, carbon-based microbes that could ... Saturn,s Enceladus. The three-year project, funded by a ... for Exploring Planets (ASTEP) program, will be led by ...
... are being found increasingly in the environmentand in environmental ... properties, especially as antibacterial and antifungal agents, silver nanoparticles ... industrial and consumer products. This, in turn, has raised ... the environment. Now a new research paper* adds an ...
... on the long-awaited era of the "$1,000 genome" a time ... deciphered for about that amount compared to nearly $1 million ... of Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, raises the ... estimate, is necessary to analyze that genetic data so it can ...
Cached Biology News:NASA project eyes climate change in Greenland -- with a third eye on Mars 2NASA project eyes climate change in Greenland -- with a third eye on Mars 3Silver cycle: New evidence for natural synthesis of silver nanoparticles 2
... Data System (CDS) now provides integrated ... data processing and reporting for the ... The companys innovative HPLC instrument has ... of Thermo Scientific Hypersil GOLD 1.9 ...
...
...
... Exiqon's miRCURY LNA technology enables sensitive ... Northern blotting. miRCURY LNA Detection probes have ... specific and sensitive detection of miRNAs. Due ... miRCURY LNA probes less than 1/10 the ...
Biology Products: